KDM3B and rhabdomyosarcoma: Suppressed xenograft tumor growth of PAX3-FOXO1 fusion-positive rhabdomyosarcoma and delayed tumor progression were the effects of a dual LSD1 and KDM3B inhibitor, called PFI-90 [55].